High-content imaging plays a pivotal role in modern drug discovery for capturing detailed cellular responses at scale. As assays expand in complexity, researchers need faster, more powerful tools. In this webinar, experts will share real-world applications that showcase how next-generation imaging platforms and AI-driven software are pushing the boundaries of phenotypic profiling and organoid-based studies, enhancing reproducibility, scalability, and discovery potential.
Topics to be covered:
- High-content imaging assays for 2D phenotypic profiling and 3D patient-derived organoid analysis
- The latest innovations in high-content screening platforms that enhance speed, quality, and flexibility
- How AI-driven analysis can improve reproducibility and tackle challenging screening assays
